Prevalence of Mitochondrial 1555A>G Mutation in European Children

被引:117
作者
Bitner-Glindzicz, Maria [1 ]
Pembrey, Marcus [1 ]
Duncan, Andrew [1 ]
Heron, Jon [2 ]
Ring, Susan M. [2 ]
Hall, Amanda [2 ]
Rahman, Shamima [3 ]
机构
[1] UCL Inst Child Hlth, London WC1N 1EH, England
[2] Univ Bristol, Bristol BS8 1TH, Avon, England
[3] MRC, Ctr Neuromuscular Dis, London WC1N 3BG, England
基金
英国惠康基金; 英国医学研究理事会;
关键词
AMINOGLYCOSIDES; DEAFNESS;
D O I
10.1056/NEJMc0806396
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:640 / 642
页数:3
相关论文
共 6 条
[1]   Ototoxicity caused by aminoglycosides [J].
Bitner-Glindzicz, Maria ;
Rahman, Shamima .
BMJ-BRITISH MEDICAL JOURNAL, 2007, 335 (7624) :784-785
[2]   Familial progressive sensorineural deafness is mainly due to the mtDNA A1555G mutation and is enhanced by treatment with aminoglycosides [J].
Estivill, X ;
Govea, N ;
Barceló, A ;
Perelló, E ;
Badenas, C ;
Romero, E ;
Moral, L ;
Scozzari, R ;
D'Urbano, L ;
Zeviani, M ;
Torroni, A .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (01) :27-35
[3]   GENETIC-ASPECTS OF ANTIBIOTIC INDUCED DEAFNESS - MITOCHONDRIAL INHERITANCE [J].
HU, DN ;
QIU, WQ ;
WU, BT ;
FANG, LZ ;
ZHOU, F ;
GU, YP ;
ZHANG, QH ;
YAN, JH ;
DING, YQ ;
WONG, H .
JOURNAL OF MEDICAL GENETICS, 1991, 28 (02) :79-83
[4]   A MOLECULAR-BASIS FOR HUMAN HYPERSENSITIVITY TO AMINOGLYCOSIDE ANTIBIOTICS [J].
HUTCHIN, T ;
HAWORTH, I ;
HIGASHI, K ;
FISCHEGHODSIAN, N ;
STONEKING, M ;
SAHA, N ;
ARNOS, C ;
CORTOPASSI, G .
NUCLEIC ACIDS RESEARCH, 1993, 21 (18) :4174-4179
[5]   A new human genetic resource: a DNA bank established as part of the Avon Longitudinal Study of Pregnancy and Childhood (ALSPAC) [J].
Jones, RW ;
Ring, S ;
Tyfield, L ;
Hamvas, R ;
Simmons, H ;
Pembrey, M ;
Golding, J .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2000, 8 (09) :653-660
[6]   Prevalence of Mitochondrial 1555A>G Mutation in Adults of European Descent [J].
Vandebona, Himesha ;
Mitchell, Paul ;
Manwaring, Neil ;
Griffiths, Kate ;
Gopinath, Bamini ;
Wang, Jie Jin ;
Sue, Carolyn M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (06) :642-644